These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

103 related items for PubMed ID: 11864339

  • 1. Molecular epidemiology of quinolone resistance in Acinetobacter spp.
    Seward RJ, Towner KJ.
    Clin Microbiol Infect; 1998 May; 4(5):248-254. PubMed ID: 11864339
    [Abstract] [Full Text] [Related]

  • 2. Detection of mutations in the gyrA and parC genes in quinolone-resistant clinical isolates of Enterobacter cloacae.
    Deguchi T, Yasuda M, Nakano M, Ozeki S, Kanematsu E, Nishino Y, Ishihara S, Kawada Y.
    J Antimicrob Chemother; 1997 Oct; 40(4):543-9. PubMed ID: 9372424
    [Abstract] [Full Text] [Related]

  • 3. Amino acid substitutions of quinolone resistance determining regions in GyrA and ParC associated with quinolone resistance in Acinetobacter baumannii and Acinetobacter genomic species 13TU.
    Liu YH, Kuo SC, Lee YT, Chang IC, Yang SP, Chen TL, Fung CP.
    J Microbiol Immunol Infect; 2012 Apr; 45(2):108-12. PubMed ID: 22153765
    [Abstract] [Full Text] [Related]

  • 4. Substitutions of Ser83Leu in GyrA and Ser80Leu in ParC Associated with Quinolone Resistance in Acinetobacter pittii.
    Gu DX, Hu YJ, Zhou HW, Zhang R, Chen GX.
    Microb Drug Resist; 2015 Jun; 21(3):345-51. PubMed ID: 25514581
    [Abstract] [Full Text] [Related]

  • 5. Quinolone-resistance mutations in the topoisomerase IV parC gene of Acinetobacter baumannii.
    Vila J, Ruiz J, Goñi P, Jimenez de Anta T.
    J Antimicrob Chemother; 1997 Jun; 39(6):757-62. PubMed ID: 9222045
    [Abstract] [Full Text] [Related]

  • 6. Analysis of the mechanisms of quinolone resistance in clinical isolates of Citrobacter freundii.
    Navia MM, Ruiz J, Ribera A, de Anta MT, Vila J.
    J Antimicrob Chemother; 1999 Dec; 44(6):743-8. PubMed ID: 10590274
    [Abstract] [Full Text] [Related]

  • 7. Novel Ser79Leu and Ser81Ile substitutions in the quinolone resistance-determining regions of ParC topoisomerase IV and GyrA DNA gyrase subunits from recent fluoroquinolone-resistant Streptococcus pneumoniae clinical isolates.
    Korzheva N, Davies TA, Goldschmidt R.
    Antimicrob Agents Chemother; 2005 Jun; 49(6):2479-86. PubMed ID: 15917550
    [Abstract] [Full Text] [Related]

  • 8. Ciprofloxacin and nalidixic acid resistance of Salmonella spp. isolated from retail food in Poland.
    Mąka Ł, Maćkiw E, Stasiak M, Wołkowicz T, Kowalska J, Postupolski J, Popowska M.
    Int J Food Microbiol; 2018 Jul 02; 276():1-4. PubMed ID: 29649749
    [Abstract] [Full Text] [Related]

  • 9. Mutation patterns in gyrA and parC genes of ciprofloxacin resistant isolates of Neisseria gonorrhoeae from India.
    Chaudhry U, Ray K, Bala M, Saluja D.
    Sex Transm Infect; 2002 Dec 02; 78(6):440-4. PubMed ID: 12473806
    [Abstract] [Full Text] [Related]

  • 10. Correlation of in vitro susceptibilities to newer quinolones of naturally occurring quinolone-resistant Neisseria gonorrhoeae strains with changes in GyrA and ParC.
    Shultz TR, Tapsall JW, White PA.
    Antimicrob Agents Chemother; 2001 Mar 02; 45(3):734-8. PubMed ID: 11181352
    [Abstract] [Full Text] [Related]

  • 11. Co-existence of plasmid-mediated quinolone resistance determinants and mutations in gyrA and parC among fluoroquinolone-resistant clinical Enterobacteriaceae isolated in a tertiary hospital in Warsaw, Poland.
    Piekarska K, Wołkowicz T, Zacharczuk K, Rzeczkowska M, Chróst A, Bareja E, Olak M, Gierczyński R.
    Int J Antimicrob Agents; 2015 Mar 02; 45(3):238-43. PubMed ID: 25468717
    [Abstract] [Full Text] [Related]

  • 12. Comparison of gyrA and parC mutations and resistance levels among fluoroquinolone-resistant isolates and laboratory-derived mutants of oral streptococci.
    Kaneko A, Sasaki J, Shimadzu M, Kanayama A, Saika T, Kobayashi I.
    J Antimicrob Chemother; 2000 Jun 02; 45(6):771-5. PubMed ID: 10837428
    [Abstract] [Full Text] [Related]

  • 13. Prevalence of gyrA Mutations in Nalidixic Acid-Resistant Strains of Salmonella Enteritidis Isolated from Humans, Food, Chickens, and the Farm Environment in Brazil.
    Campioni F, Souza RA, Martins VV, Stehling EG, Bergamini AMM, Falcão JP.
    Microb Drug Resist; 2017 Jun 02; 23(4):421-428. PubMed ID: 27559761
    [Abstract] [Full Text] [Related]

  • 14. In vitro selection of fluoroquinolone-resistant Neisseria gonorrhoeae harboring alterations in DNA gyrase and topoisomerase IV.
    Yasuda M, Fukuda H, Yokoi S, Ishihara S, Kawada Y, Deguchi T.
    J Urol; 2000 Sep 02; 164(3 Pt 1):847-51. PubMed ID: 10953166
    [Abstract] [Full Text] [Related]

  • 15. Insertion sequence disruption of adeR and ciprofloxacin resistance caused by efflux pumps and gyrA and parC mutations in Acinetobacter baumannii.
    Lopes BS, Amyes SG.
    Int J Antimicrob Agents; 2013 Feb 02; 41(2):117-21. PubMed ID: 23217848
    [Abstract] [Full Text] [Related]

  • 16. Mutations in gyrA and parC genes in nalidixic acid-resistant Escherichia coli strains from food products, humans and animals.
    Sáenz Y, Zarazaga M, Briñas L, Ruiz-Larrea F, Torres C.
    J Antimicrob Chemother; 2003 Apr 02; 51(4):1001-5. PubMed ID: 12654733
    [Abstract] [Full Text] [Related]

  • 17. The acquisition of full fluoroquinolone resistance in Salmonella Typhi by accumulation of point mutations in the topoisomerase targets.
    Turner AK, Nair S, Wain J.
    J Antimicrob Chemother; 2006 Oct 02; 58(4):733-40. PubMed ID: 16895934
    [Abstract] [Full Text] [Related]

  • 18. Genetic basis of quinolone resistance and epidemiology of resistant and susceptible isolates of porcine Campylobacter coli strains.
    Cooper R, Segal H, Lastovica AJ, Elisha BG.
    J Appl Microbiol; 2002 Oct 02; 93(2):241-9. PubMed ID: 12147072
    [Abstract] [Full Text] [Related]

  • 19. Molecular basis of high-level ciprofloxacin resistance in Neisseria gonorrhoeae strains isolated in Denmark from 1995 to 1998.
    Su X, Lind I.
    Antimicrob Agents Chemother; 2001 Jan 02; 45(1):117-23. PubMed ID: 11120953
    [Abstract] [Full Text] [Related]

  • 20. Molecular epidemiology and mutations at gyrA and parC genes of ciprofloxacin-resistant Escherichia coli isolates from a Taiwan medical center.
    Chen JY, Siu LK, Chen YH, Lu PL, Ho M, Peng CF.
    Microb Drug Resist; 2001 Jan 02; 7(1):47-53. PubMed ID: 11310803
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.